News

Alcon has received FDA approval for its AcrySof IQ PanOptix Trifocal IOL, and the company is rolling out its initial commercial launch of the product.

Dr. Kaiser discusses how risuteganib fared in a phase II trial in patients with intermediate nonexudative AMD. 

Failure to address problems with the tear film and ocular surface before surgery can negatively affect surgical outcomes and patient satisfaction.

Eye issues may have been factor for historic military leader

ICYMI: Dr. Blinder compares the efficiencies between two surgical cutters

Removal of object may depend on potential risk, impact on patient’s vision

No cookie-cutter procedure, UEB can improve patients’ visual fields by more than 25%

Low to moderate myopes are among the most challenging patients to satisfy with cataract surgery

Eyes with persistent subretinal fluid fared better with visual acuity than eyes that were dry, according to the HARBOR Trial

Glaucoma specialists deal with numerous routine considerations on a daily basis. Andrew Iwach, MD, enumerated some of these consideration and discussed the bright spots and the pitfalls.

Uveitic glaucoma presents a treatment challenge because of the need to control two conditions. Furthermore, side effects of conventional treatments for uveitis-corticosteroids and systemic immunomodulatory agents-limit their use.

Short drive times, access to transportation play role in maintaining eye health appointments

Glaucoma genetics research can define the molecular basis of glaucoma and targets for developing curative or even preventive therapies, and it also pro-vides a basis for diagnostic and screening tests.

Sixty-five genes identified with several belonging to signaling pathways

Here's how hospital stays can affect vision

JAMA Ophthalmology investigates the accuracy claims of this convenient modality 

We can all become true experts by channeling the passion for ocular surgery, according to Uday Devgan, MD, FACS.

Voting for the 2019 Ophthalmology Times Resident Writers Award Program is now open!

Our supply of dorzolamide, long a first-line glaucoma therapy used alone or in fixed combination with timolol, has recently proven unreliable.

Annual survey from ASCRS/ESCRS pinpoints trends in explantation

A diffractive trifocal IOL achieved satisfactory vision with a high rate of spectacle independence